PHIO FY 2023 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6M

Operating Income

-$11M

Net Income

-$11M

EPS (Diluted)

$-46.76

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$303,000

Balance Sheet

Total Assets

$9M

Total Liabilities

$2M

Stockholders' Equity

$8M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6M	-$7M	+9.7%
Operating Income	-$11M	-$11M	+5.6%
Net Income	-$11M	-$11M	+5.7%